Human Dominance or Human Vulnerability?: Reviewing Amitav Ghosh’s The Living Mountain: a Fable for Our Times
transcript: An e-Journal of Literary and Cultural Studies · 2022
DOI: 10.53034/transcript.2022.v02.n02.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift transcript: An e-Journal of Literary and Cultural Studies, 2022. Verfasst von Somasree Sarkar.
Abstract (Originalsprache)
The term ‘Anthropocene’ – the human-dominated epoch has emphasised the evolution of human beings as the dominating species causing the environmental changes and affecting the current climate crisis. The proposal of the Anthropocene as the new geological epoch integrally entangles the human world with the geophysical world, insisting that human history can hardly be separated from environmental history. Realising that both worlds are entangled, it underpins an environmental consciousness among environmental thinkers. Their consciousness rests on their understanding of human beings’ vulnerability to being intertwined with the fragile ecosystem. In this review, I attempt to place Amitav Ghosh’s The Living Mountain: a Fable for Our Times (2022) within Anthropocene discourses which consider human beings as the dominating species in the current epoch, while remaining vulnerable to their destructive activities.
Zitieren
APA
Sarkar, S. (2022). Human Dominance or Human Vulnerability?: Reviewing Amitav Ghosh’s The Living Mountain: a Fable for Our Times. transcript: An e-Journal of Literary and Cultural Studies. https://doi.org/10.53034/transcript.2022.v02.n02.005
Vancouver
Sarkar S. Human Dominance or Human Vulnerability?: Reviewing Amitav Ghosh’s The Living Mountain: a Fable for Our Times. transcript: An e-Journal of Literary and Cultural Studies. 2022. doi:10.53034/transcript.2022.v02.n02.005
BibTeX
@article{Sarkar2022,
author = {Sarkar, Somasree},
title = {Human Dominance or Human Vulnerability?: Reviewing Amitav Ghosh’s The Living Mountain: a Fable for Our Times},
journal = {transcript: An e-Journal of Literary and Cultural Studies},
year = {2022},
doi = {10.53034/transcript.2022.v02.n02.005}
}
EUVIMED